Skip to main content
logo
Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
15.65
-0.10 (-0.63%)
Jan 26, 2026, 4:00 PM EST - Market closed

Avalo Therapeutics Revenue

In the year 2024, Avalo Therapeutics had annual revenue of $441.00K, down -77.08%.

Revenue (ttm)
$441.00K
Revenue Growth
-77.08%
P/S Ratio
1,508.98
Revenue / Employee
$8,348
Employees
23
Market Cap
289.72M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024441.00K-1.48M-77.08%
Dec 31, 20231.92M-16.13M-89.34%
Dec 31, 202218.05M12.65M234.40%
Dec 31, 20215.40M-1.30M-19.42%
Dec 31, 20206.70M-51.35K-0.76%
Dec 31, 20196.75M-278.03K-3.96%
Dec 31, 20187.03M-20.78M-74.73%
Dec 31, 201727.81M26.66M2,312.27%
Dec 31, 20161.15M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 201282.76K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

AVTX News

More News